An official website of the European Union How do you know?      
European Commission logo
Locoregional Treatment of Glioblastoma With Targeted αlpha Therapy [213Bi]Bi-DOTA–Substance P Versus [225Ac]Ac-DOTA–Substance P—Analysis of Influence Parameters
cover
Glioblastoma (GB) is the most malignant primary brain tumor. Therefore, introduction of newtreatment options is critically important. The aim of this study was to assess local treatment with α emitters [213Bi]Bi- DOTA–substance P (SP) and [225Ac]Ac-DOTA-SP.
2023-10-12
LIPPINCOTT WILLIAMS & WILKINS
JRC134533
0363-9762 (online),   
https://journals.lww.com/nuclearmed/Abstract/2023/05000/Locoregional_Treatment_of_Glioblastoma_With.2.aspx,    https://publications.jrc.ec.europa.eu/repository/handle/JRC134533,   
10.1097/RLU.0000000000004608 (online),   
NameCountryCityType
Datasets
IDTitlePublic URL
Dataset collections
IDAcronymTitlePublic URL
Scripts / source codes
DescriptionPublic URL
Additional supporting files
File nameDescriptionFile type 
Show metadata record  Copy citation url to clipboard  Download BibTeX